Interleukin-18(IL-18) and Atherosclerosis

被引:0
|
作者
Givtaj, Nozar [1 ]
Bassiri, Hossein Ali [1 ]
Givtaj, Nader [1 ]
Simin, Asghar [1 ]
Noohi, Feridoun [1 ]
机构
[1] Univ Tehran Med Sci, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran
来源
IRANIAN HEART JOURNAL | 2012年 / 13卷 / 01期
关键词
Inflammation; Atherosclerosis; Interleukin; 18; CAD; Cytokine;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background- Atherosclerosis is a dynamic and progressive disease arising from the combination of endothelial dysfunction and inflammation. So, inflammatory mediators are important causative and progressive factors in atherosclerosis. Interleukin-18 (IL-18) is a pleiotropic cytokine which may have a key role in atherosclerosis, because the results of recent studies indicated that IL-18, either directly as a pro-inflammatory factor or indirectly as an interferon inducing factor, has central role in the inflammatory cascade. In present study, we evaluated the relation between blood concentration of IL-18 with atherosclerosis and its severity and also the relation of this cytokine with the other known risk factors of coronary artery disease (CAD). Methods- 138 patients who underwent diagnostic cardiac catheterization and had the inclusion criteria for this study, were selected. In the beginning, a questionnaire containing personal information and medical history was completed for each of them and blood samples were collected 24 hours before catheterization. We measured blood level of IL-18 and CRP in all samples. The results of these tests and the angiography were entered in the questionnaire and then information was analyzed using regression analyzing, K2 and statistical T test. P values of <0.05 were considered statistically significant. Results- By using the results of angiography, patients were divided in two groups. 1-Control group or normal coronary arteries (32 people) 2- Case group (106 people) or patients who were suffering from CAD. In second group, 6 patients (5.6%) had minimal CAD, 44 patients (41.5%) had single-vessel disease (SVD), 27 patients (25.4%) had 2VD and 29 patients (27.5%) had 3VD. In the laboratory tests, the mean IL-18 blood level in patients with CAD was 258.1 pgr/ml but in normal coronary arteries group it was 216.6 pgr/ml. The average blood level of IL-18 in patients who had minimal CAD was 235.5 pgr/ml, in SVD was 247.2 pgr/ml, in 2VD was 263.7 pgr/ml and in patients with 3VD was 274.1 pgr/ml. Also average CRP blood level in normal group was 8.9 mgr/L while in patients with CAD it was 20.4 mgr/L. Conclusion- The results of this study indicated that there was a direct and significant correlation between blood IL-18 level with existence (P<0.001) and severity of CAD (P<0.01) and IL-18 can be an independent predictor risk factor of atherosclerosis.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 50 条
  • [21] Normal Free Interleukin-18 ( IL-18) Plasma Levels in Dengue Virus Infection and the Need To Measure Both Total IL-18 and IL-18 Binding Protein Levels
    Michels, Meta
    de Mast, Quirijn
    Netea, Mihai G.
    Joosten, Leo A.
    Dinarello, Charles A.
    Rudiman, Pandji I. F.
    Sinarta, Sylvia
    Wisaksana, Rudi
    Alisjahbana, Bachti
    van der Ven, Andre J. A. M.
    CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (06) : 650 - 655
  • [22] Serum and peritoneal correlation of interleukin-18 (IL-18) in infertile women with endometriosis.
    Cunha-Filho, J. S.
    Glitz, C. L.
    Berton, G.
    Senger, M.
    Freitas, F. M.
    Passos, E. P.
    FERTILITY AND STERILITY, 2006, 86 : S259 - S260
  • [23] The role of interleukin-18 (IL-18) in animal models of septic shock and septic arthritis
    Ghayur, T
    Murtaza, A
    Tissi, L
    Puliti, M
    McRae, B
    Tracey, D
    SHOCK, 2004, 21 : 67 - 67
  • [24] Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer
    Tas, Faruk
    Yasasever, Ceren Tilgen
    Karabulut, Senem
    Tastekin, Didem
    Duranyildiz, Derya
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 70 : 19 - 23
  • [25] Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii
    Cai, GF
    Kastelein, R
    Hunter, CA
    INFECTION AND IMMUNITY, 2000, 68 (12) : 6932 - 6938
  • [26] Human antibody recognizing the epitope of interleukin-18 binding site III for IL-18 receptor
    Hamasaki, T
    Hashiguchi, S
    Ito, Y
    Nakanishi, K
    Sugimura, K
    IMMUNOLOGY 2004: CYTOKINE NETWORK, REGULATORY CELLS, SIGNALING, AND APOPTOSIS, 2004, : 381 - 384
  • [27] Interleukin-18 (IL-18) and infectious diseases, with special emphasis on diseases induced by intracellular pathogens
    Sugawara, I
    MICROBES AND INFECTION, 2000, 2 (10) : 1257 - 1263
  • [28] Regulation of interleukin-18 (IL-18) expression in keratinocytes (HaCaT):: implications for early wound healing
    Kämpfer, H
    Mühl, H
    Manderscheid, M
    Kalina, U
    Kauschat, D
    Pfeilschifter, J
    Frank, S
    EUROPEAN CYTOKINE NETWORK, 2000, 11 (04) : 626 - 633
  • [29] Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease
    Ludwiczek, O
    Kaser, A
    Novick, D
    Dinarello, CA
    Rubinstein, M
    Tilg, H
    EUROPEAN CYTOKINE NETWORK, 2005, 16 (01) : 27 - 33